Biolife Sciences (Biolife Sciences) Total Stockholders Equity : $-0.42 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Total Stockholders Equity?

Biolife Sciences's Total Stockholders Equity for the quarter that ended in May. 2008 was $-0.42 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Biolife Sciences's Book Value per Share for the quarter that ended in May. 2008 was $-79.81. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Biolife Sciences's Debt-to-Equity for the quarter that ended in May. 2008 was -6.82.

Biolife Sciences Total Stockholders Equity Historical Data

The historical data trend for Biolife Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Total Stockholders Equity Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Total Stockholders Equity

0.07

0.25

0.06

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Total Stockholders Equity	Get a 7-Day Free Trial										0.21	0.22	0.06	-0.20	-0.42

Biolife Sciences (OTCPK:BLFE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Biolife Sciences's Book Value per Share for the quarter that ended in May. 2008 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.419	-	0)	/	0.00525
	=	-79.81

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Biolife Sciences's Debt-to-Equity for the quarter that ended in May. 2008 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.437	+	0.421)	/	-0.419
	=	-6.82

Biolife Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020